Brief: Neurotrope Announces Top-Line Results From Confirmatory Phase 2 Study Of Bryostatin-1 In Moderate To Severe Alzheimer's Disease

NextTrip

09/09/2019 14:50

Sept 9 (Reuters) - Neurotrope Inc  NTRP.O :
    * NEUROTROPE ANNOUNCES TOP-LINE RESULTS FROM CONFIRMATORY
PHASE 2
STUDY OF BRYOSTATIN-1 IN MODERATE TO SEVERE ALZHEIMER'S DISEASE
    * NEUROTROPE INC - CONFIRMATORY PHASE 2 STUDY OF
BRYOSTATIN-1 IN
MODERATE TO SEVERE AD DID NOT ACHIEVE STATISTICAL SIGNIFICANCE
ON PRIMARY ENDPOINT
    * NEUROTROPE - NO STATISTICALLY SIGNIFICANT DIFFERENCE
OBSERVED IN
CHANGE FROM BASELINE IN SIB TOTAL SCORE BETWEEN BRYOSTATIN-1 &
PLACEBO TREATMENT GROUPS
    * NEUROTROPE INC - "CONDUCTING A FULL REVIEW TO DETERMINE
POTENTIAL NEXT STEPS"

Source text for Eikon:  ID:nPn2b0k7Ma 
Further company coverage:  NTRP.O 

 ((Reuters.Briefs@thomsonreuters.com;))